William Blair Initiates Coverage on Zentalis Pharmaceuticals (NASDAQ ...

William Blair Initiates Coverage of Reneo Pharmaceuticals (RPHM) with ...

William Blair Initiates Coverage of Reneo Pharmaceuticals (RPHM) with ...

William Blair Initiates Coverage of Zillow Group (BRSE:0ZG) with Market ...

William Blair Initiates Coverage of APi Group (APG) with Outperform ...

William Blair Initiates Coverage of Compass Therapeutics (CMPX) with ...

William Blair Initiates Coverage of Enovis (ENOV) with Outperform ...

William Blair Initiates Coverage of Paragon 28 (FNA) with Outperform ...

William Blair Initiates Coverage of UiPath (PATH) with Outperform ...

William Blair Initiates Coverage of Enovis (ENOV) with Outperform ...

William Blair Initiates Coverage of Ultragenyx Pharmaceutical (LSE:0LIF ...

William Blair Initiates Coverage on UIS with Outperform Rating

William Blair Initiates Coverage of Immunic (IMUX) with Outperform ...

William Blair Initiates Coverage of MP Materials (MP) with Outperform ...

William Blair Initiates Coverage of BrightSpring Health Services (BTSG ...

William Blair initiates coverage of BridgeBio Pharma (BBIO) with ...

William Blair Initiates Coverage of Lifecore Biomedical (LFCR) with ...

William Blair Initiates Coverage of Federal Signal (FSS) with ...

William Blair initiates coverage on Dave (DAVE)

William Blair Initiates Coverage of Context Therapeutics (CNTX) with ...

William Blair Initiates Coverage on Allot with Outperform Rating

William Blair Initiates Coverage of OneStream Software (OS) with ...

William Blair Initiates Coverage of Amprius Technologies (AMPX) with ...

Zentalis Pharmaceuticals on LinkedIn: Nasdaq congratulated Zentalis ...

William Blair is proud to have initiated equity research coverage of ...

William Blair is proud to have initiated equity research coverage of 13 ...

William Blair is proud to have initiated equity research coverage of ...

William Blair is proud to have initiated equity research coverage of ...

William Blair is proud to have initiated equity research coverage of ...

William Blair hires Daniel Nilsson for Nordic PE coverage | William ...

William Blair is proud to have initiated equity research coverage of ...

William Blair is proud to have initiated equity research coverage of ...

Zentalis Pharmaceuticals on LinkedIn: Today, we announced financial ...

Rambus Stock Surges as William Blair Initiates Positive Coverage

William Blair is proud to have initiated equity research coverage of ...

William Blair Investment Banking on LinkedIn: William Blair Expands ...

ZNTL Stock Price, Quote & Chart | ZENTALIS PHARMACEUTICALS INC (NASDAQ ...

Zentalis Pharmaceuticals on LinkedIn: Today the Zentalis team is ...

Rambus Stock Surges as William Blair Initiates Positive Coverage

Zentalis Pharmaceuticals on LinkedIn: Today, we announced the ...

Fintech Leaders: SoFi and Affirm Shine as William Blair Initiates ...

Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq ...

ZNTL Stock Price - Zentalis Pharmaceuticals Inc Stock Candlestick Chart ...

Wells Fargo Maintains Zentalis Pharmaceuticals (ZNTL) Overweight ...

Zentalis Pharmaceuticals Appoints Melissa Epperly as Chief Financial ...

Immunic, Inc.: Initiation of Research Coverage | William Blair

UBS Group Lowers Zentalis Pharmaceuticals (NASDAQ:ZNTL) to Neutral ...

Zentalis Pharmaceuticals Announces Strategic Restructuring to Support ...

William Blair Initiates Suja Life at Outperform | FINWIRES

William Blair on LinkedIn: #williamblairthinking

William Blair has named Terence Tan as managing director in the firm’s ...

Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing ...

Pennant Group (PNTG): Revisiting Valuation After William Blair ...

Coverage | William Blair

William Blair Announces Five Strategic Hires Across Equities and Equity ...

Zentalis Pharmaceuticals on LinkedIn: #oncology

William Blair on LinkedIn: Client Focus

William Blair hires industry veteran for fund placement, secondary ...

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Is In A Good Position To Deliver ...

William Blair Invests in Nonprofits to Strengthen Financial Services ...

Zentalis Pharmaceuticals (NASDAQ:ZNTL) Receives Buy Rating from ...

Analyst Thursdays: William Blair Senior Analyst Andy Hsieh talks about ...

William Blair Initiates US Antimony With Outperform as D... | FMP

Leadership Shift at Zentalis as New Legal Chief Takes Helm Amid ...

Zentalis (ZNTL) Tanks After FDA Puts 3 Cancer Studies on Hold

ZENTALIS PHARMACEUTICALS AKTIEN News | A2P209 Nachrichten

ZENTALIS PHARMACEUTICALS AKTIEN News | A2P209 Nachrichten

ZNTL - Zentalis Pharmaceuticals, Inc. Stock - Stock Price ...

Today, Zentalis announced an equity investment from Pfizer, as well as ...

Zentalis Pharmaceuticals logo in transparent PNG format

Equity Research | William Blair

Zentalis Pharmaceuticals LLC (NASD:ZNTL) Seasonal Chart | Equity Clock

William Blair: Medicare price negotiations could have an impact ...

William Blair Names Global Head of Investment Management | William Blair

Zentalis Pharmaceuticals - Crunchbase Company Profile & Funding

Astera Labs Inc Initiation | William Blair

Zentalis Pharmaceuticals Surges After Promising Azenosertib Developments

Pomerantz Law Firm Looks into Securities Fraud Claims Against Zentalis ...

Zentalis Pharmaceuticals | LinkedIn

Zentalis Pharmaceuticals - Web Excellence Awards

Zentalis Pharmaceuticals (@ZentalisP) / Twitter

William Blair Growth Stock Conference 2024 | William Blair

Podcast | William Blair

Zentalis Pharmaceuticals Employee Perks & Benefits | Levels.fyi

Zentalis Pharmaceuticals LLC (NASD:ZNTL) Seasonal Chart | Equity Clock

William Blair | Homepage

Zentalis Pharmaceuticals Provides Corporate Update and

William Blair | Homepage

Zentalis Pharmaceuticals - Web Excellence Awards

Zentalis Pharmaceuticals, State of the Art Clinical-Stage Biopharma ...

John Kreger has been named director of research for William Blair's ...

Embracing the Qualitative | William Blair

Today, Zentalis announced the promotion of Co-founder Kevin Bunker, Ph ...

William Blair Maintains Apellis Pharmaceuticals(APLS.US) With Buy Rating

William Blair Receives Top Workplaces Awards | William Blair

William Blair abre oficina en Madrid | DiarioAbiertoDiarioAbierto

Updated DENALI trial data shows promise in ovarian cancer | Zentalis ...

Zentalis Pharmaceuticals, Inc.'s (NASDAQ:ZNTL) Shares Bounce 28% But ...

Steven Lichtman | William Blair

Zentalis Pharmaceuticals LLC (NASD:ZNTL) Seasonal Chart | Equity Clock

Zentalis Pharmaceuticals Becomes Oversold (ZNTL) | Nasdaq

ZNTL Q4 2025 Earnings Report on 3/26/2026

ZNTL - Zentalis Pharma | Fundamentei

ZNTL Q4 2024 Earnings Report on 3/26/2025

Zentalis Pharma Advances Stir Market as Azenosertib Program Strengthens

Guggenheim Increases Zentalis Price Target, Sparking Investor Interest

ZNTL Q2 2025 Earnings Report on 8/6/2025

How Targeted Therapy Breakthroughs are Improving Alzheimers Treatment ...

Zentalis Presents Azenosertib Data for Breast and Ovarian Cancer

Circle (CRCL) Called ‘Most Important’ Stablecoin Player by Investment ...

Automation, Scale, and Acquisition Leading the Digital Transformation ...

We look forward to a productive 2023 across our portfolio as we ...

ZNTL Q1 2026 Earnings Report on 5/12/2026

slide1

First-in-class ：Zentalis启动与辉瑞的首个合作项目，开发选择性Wee1抑制剂ZN-c3|抑制剂|药物|患者|癌症|肿瘤|-健康界

2例患者死亡，WEE1抑制剂3项临床研究遭FDA暂停，Zentalis股价大跌50%医药新闻-ByDrug-一站式医药资源共享中心-医药魔方

IPO ‘roadshows’ from home cause bankers to question the old ways

2月，6位跨国药企高管变动！_摩熵医药(原药融云)

slide3

2例患者死亡，WEE1抑制剂3项临床研究遭FDA暂停，Zentalis股价大跌50%医药新闻-ByDrug-一站式医药资源共享中心-医药魔方

First-in-class ：Zentalis启动与辉瑞的首个合作项目，开发选择性Wee1抑制剂ZN-c3